Retrospective analysis of screening for SARS-CoV-2 in obstetrics and
gynecology outpatients after the peak of the outbreak in Wuhan
Abstract
Objective: To analyze covid-19-associated test results and optimize
screening procedure for obstetrics and gynecology outpatients Design:
Single center retrospective study. Setting: Union Hospital, Tongji
Medical College, Huazhong University of Science and Technology, Wuhan,
Hubei province, P.R. China. Population or Sample: A total of 1,051
obstetrics and gynecology outpatients were included in the study from
March 12 to April 26, 2020. Methods: We collected medical records,
COVID-19-associated test results and reported the visit procedure for
obstetrics and gynecology outpatients. Main outcome(s) and measure(s):
We analyzed covid-19-associated test results and followed up the
patients. Results: After reviewing the visit procedure, a total of 1051
obstetrics and gynecology outpatients were included in the study, and a
series of COVID-19 tests were conducted, which included the SARS-CoV-2
nucleic acid test, chest CT scan and SARS-CoV-2-specific serological
test. The SARS-CoV-2 nucleic acid test was negative in all 1051
patients. None of the patients admitted to the hospital experienced
SARS-CoV-2 infections during hospitalization. Seventy-six cases were
diagnosed with abnormal uterine bleeding-related disease (excluding
endometrial malignancy), 2019-nCoV antibody positive rate was 6.579%,
which is greater than the average positive rate of 3.974%, and the
positive rate among patients with other diseases. No nucleic acid
positivity was found in the follow-up of 9 IgM+ (and IgG+) patients.
Conclusions: As the peak of the epidemic has passed, a more optimized
screening procedure is required to avoid hospital infections.